Cloud-led Future · Intelligence-driven Hotline +86 21 6228 0217 中文 | EN

Non-Auto Premium Overtakes Auto for the First Time as P&C Structure Shifts and Underwriting Resilience Improves

Overview

An industry analysis published by Eastmoney on November 13 identifies a structural milestone in China’s property and casualty sector: against a backdrop of slowing overall growth, non-auto premium has overtaken auto insurance for the first time in the business mix. The shift means auto, long the sector’s foundational book, has ceded its dominant share to non-auto lines as a whole, changing both the growth engine and the risk profile. Operating data disclosed over the same period show that 59 P&C insurers recorded year-on-year declines in their combined ratios, with both the expense ratio and the loss ratio falling versus a year earlier — a clear improvement in underwriting resilience across the industry.

Better underwriting coexists with intensifying competition. Among non-auto segments, health insurance is a priority for many small and mid-sized insurers, yet overall growth in health cover has begun to slow, the short-term medical products that expanded rapidly in recent years are losing momentum, and industry-wide claims pressure keeps rising. To reduce loss ratios, some P&C insurers are integrating upstream and downstream medical resources and building integrated health-management and medical-service ecosystems, attempting to curb unreasonable claims at source through upfront health management and connected medical data, thereby improving health-line profitability.

Building such ecosystems, however, carries a pronounced scale threshold. The analysis argues that large insurers, leveraging capital strength, customer bases and channel resources, have erected high barriers, making it difficult for smaller players to compete head-on across the full product spectrum. In response, some smaller insurers are turning to niche strategies — abandoning all-population, all-product coverage in favour of specific groups and specific diseases, offering more targeted protection in segments not yet fully served by leading firms. The sector’s central questions are whether smaller insurers can break through resource barriers through differentiation, and whether improved non-auto underwriting profit can consistently offset volatility on the investment side.

Background & Interpretation

1. Regulatory and Industry Context

Since comprehensive auto insurance reform, average premiums per vehicle have fallen and loss ratios risen, turning auto from a high-margin scale pillar into a mature, low-growth business demanding granular pricing; fluctuating new-car sales and the claims profile of new-energy vehicles have further narrowed its expansion room. In parallel, policy has steadily steered insurance toward serving the real economy and public welfare, opening more space for liability, agriculture, health, technology and catastrophe cover, so non-auto crossing the halfway mark is the outcome of a long-run trend. On the regulatory side, unified reporting and pricing, expense control and product suitability management have compressed channel costs and discouraged price wars, consistent with the falling expense ratio. Stronger capital constraints under the second phase of the C-ROSS solvency regime have pushed insurers from premium scale toward underwriting quality and capital efficiency.

2. Core Drivers and Underlying Mechanism

The combined ratio is the sum of the expense and loss ratios, and a simultaneous decline typically comes from three channels. First, expense governance: unified reporting and pricing plus commission controls have squeezed channel arbitrage, bringing expense ratios closer to true acquisition cost. Second, business-mix optimisation: exposure to high-loss short-term medical cover and some credit-guarantee lines has contracted while better-diversified liability and agricultural lines have grown, lowering the aggregate loss ratio. Third, upfront risk control: health management, risk-reduction services and data verification move intervention from claims handling into underwriting and ongoing management, reducing unreasonable payouts caused by information asymmetry. Health ecosystems become a large-insurer moat because they require a medical network, data interfaces, long-term customer touchpoints and advance-payment capacity all at once — heavy, long-cycle investments that smaller institutions struggle to amortise. Narrowing to specific diseases and groups trades a smaller risk pool for a more predictable claims distribution and lower acquisition cost.

3. Market Structure and Industry Chain Impact

For large insurers, non-auto leadership shifts competition from channel pricing toward service ecosystems and data capability, making medical-insurance coordination, risk reduction and specialist networks long-term commitments. For smaller insurers, full-spectrum competition becomes less viable; niche diseases, occupational groups, regional disease profiles and coverage for people with pre-existing conditions offer differentiation, but bring new problems of narrow risk pools, insufficient data samples and harder reinsurance placement. For reinsurers and insurance-technology firms, demand rises for granular pricing, medical-data verification and claims anti-fraud, creating outsourcing opportunities in third-party data services and third-party administration. For medical and pharmaceutical providers, payer involvement moving upstream means deeper engagement with care pathways, with more experiments in innovative drug and device payment, outcomes-based pricing and chronic-disease management. For consumers, product tiering and precise pricing may improve access for specific groups, but require clearer disclosure to avoid misunderstanding of covered benefits.

Implications & Outlook

Near term, whether combined ratios keep improving depends on the enforcement of expense controls and the trajectory of health-claims ratios; if medical inflation and outpatient claims keep climbing, underwriting profit could be eroded again. Medium-term variables include whether non-auto share stabilises above auto, whether niche health strategies produce sustainable profit models, and the magnitude of investment-side swings on total earnings. Long term, the move from a single auto-driven engine toward a balanced multi-line mix will reshape channel structure, talent and capital allocation, and concentration may tilt further toward institutions with ecosystem and data capabilities. Notably, crossing the halfway mark is a structural signal, not a profit guarantee: liability, agriculture and health lines demand far more pricing capability, catastrophe modelling and data depth than traditional auto, and indiscriminate expansion can accumulate long-tail risk.

Takeaways for Industry Participants

P&C insurers should ground non-auto expansion in validated pricing models and risk data, completing loss attribution by line and cohort before committing scale; for health cover they should decide explicitly between building an ecosystem and partnering with third parties to avoid duplicating heavy-asset investment. Smaller insurers choosing niches should assess risk-pool size, data availability and reinsurance support, using co-insurance or reinsurance where needed to spread long-tail exposure rather than turning differentiation into risk concentration. Medical institutions, pharmaceutical firms and data providers can watch for partnership windows created by upstream payer management, but only with compliant data authorisation and clear outcome definitions. For observers and buyers, operating quality is better judged through the components of the combined ratio, claims trends by non-auto line and investment contribution, rather than premium mix or a single combined-ratio figure.

This column compiles industry information and shares technical perspectives; it does not constitute investment advice.